VIR
Vir BiotechnologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
VIR vs peer average
34/100
VIR vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · C 3 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead is not a size peer, but it is a useful directional comparator for liver-disease strategic value and commercialization context; the contrast mostly highlights how early-stage Vir still is rather than supporting a direct multiple comparison.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VIR
Vir Biotechnology
GILD
Gilead Sciences
Grade
D
A
Momentum
89
88
Value
41
64
Sentiment
49
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs GILD
VIR / GILD
Grade Position
Below peers
VIR vs. peer average (D vs. C)
34/100
Momentum
89
VIRValue
41
GILDSentiment
49
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VIR
GILD is the first peer returned for this comparison set.